BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12394768)

  • 1. Androgen receptor length polymorphism associated with prostate cancer risk in Hispanic men.
    Balic I; Graham ST; Troyer DA; Higgins BA; Pollock BH; Johnson-Pais TL; Thompson IM; Leach RJ
    J Urol; 2002 Nov; 168(5):2245-8. PubMed ID: 12394768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial variation in CAG repeat lengths within the androgen receptor gene among prostate cancer patients of lower socioeconomic status.
    Bennett CL; Price DK; Kim S; Liu D; Jovanovic BD; Nathan D; Johnson ME; Montgomery JS; Cude K; Brockbank JC; Sartor O; Figg WD
    J Clin Oncol; 2002 Sep; 20(17):3599-604. PubMed ID: 12202660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancer.
    Sartor O; Zheng Q; Eastham JA
    Urology; 1999 Feb; 53(2):378-80. PubMed ID: 9933058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer.
    Hakimi JM; Schoenberg MP; Rondinelli RH; Piantadosi S; Barrack ER
    Clin Cancer Res; 1997 Sep; 3(9):1599-608. PubMed ID: 9815849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor gene polymorphism and prostate cancer in Taiwan.
    Huang SP; Chou YH; Chang WS; Wu MT; Yu CC; Wu T; Lee YH; Huang JK; Wu WJ; Huang CH
    J Formos Med Assoc; 2003 Oct; 102(10):680-6. PubMed ID: 14691592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnic variation in allele distribution of the androgen receptor (AR) (CAG)n repeat.
    Ackerman CM; Lowe LP; Lee H; Hayes MG; Dyer AR; Metzger BE; Lowe WL; Urbanek M;
    J Androl; 2012; 33(2):210-5. PubMed ID: 21597087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The androgen receptor CAG and GGN repeat polymorphisms and prostate cancer susceptibility in African-American men: results from the Flint Men's Health Study.
    Lange EM; Sarma AV; Ray A; Wang Y; Ho LA; Anderson SA; Cunningham JM; Cooney KA
    J Hum Genet; 2008; 53(3):220-226. PubMed ID: 18217192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk.
    Stanford JL; Just JJ; Gibbs M; Wicklund KG; Neal CL; Blumenstein BA; Ostrander EA
    Cancer Res; 1997 Mar; 57(6):1194-8. PubMed ID: 9067292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor CAG polymorphism and sporadic and early-onset prostate cancer among Mexican men.
    Gómez R; Torres-Sánchez L; Camacho-Mejorado R; Burguete-García AI; Vázquez-Salas RA; Martínez-Nava GA; Santana C; Noris G
    J Hum Genet; 2016 Sep; 61(9):781-6. PubMed ID: 27193223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor CAG repeat polymorphism in prostate cancer from a Brazilian population.
    Santos ML; Sarkis AS; Nishimoto IN; Nagai MA
    Cancer Detect Prev; 2003; 27(5):321-6. PubMed ID: 14585317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
    Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of a correlation of androgen receptor gene CAG repeat length and prostate cancer risk in an African-American population.
    Gilligan T; Manola J; Sartor O; Weinrich SP; Moul JW; Kantoff PW
    Clin Prostate Cancer; 2004 Sep; 3(2):98-103. PubMed ID: 15479493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk.
    Modugno F; Weissfeld JL; Trump DL; Zmuda JM; Shea P; Cauley JA; Ferrell RE
    Clin Cancer Res; 2001 Oct; 7(10):3092-6. PubMed ID: 11595700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer.
    Giovannucci E; Stampfer MJ; Krithivas K; Brown M; Dahl D; Brufsky A; Talcott J; Hennekens CH; Kantoff PW
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3320-3. PubMed ID: 9096391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphic GGC repeats in the androgen receptor gene are associated with hereditary and sporadic prostate cancer risk.
    Chang BL; Zheng SL; Hawkins GA; Isaacs SD; Wiley KE; Turner A; Carpten JD; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB; Xu J
    Hum Genet; 2002 Feb; 110(2):122-9. PubMed ID: 11935317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk.
    Bratt O; Borg A; Kristoffersson U; Lundgren R; Zhang QX; Olsson H
    Br J Cancer; 1999 Oct; 81(4):672-6. PubMed ID: 10574254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor.
    Ingles SA; Ross RK; Yu MC; Irvine RA; La Pera G; Haile RW; Coetzee GA
    J Natl Cancer Inst; 1997 Jan; 89(2):166-70. PubMed ID: 8998186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer.
    Schildkraut JM; Murphy SK; Palmieri RT; Iversen E; Moorman PG; Huang Z; Halabi S; Calingaert B; Gusberg A; Marks JR; Berchuck A
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):473-80. PubMed ID: 17372242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. South Indian men with reduced CAG repeat length in the androgen receptor gene have an increased risk of prostate cancer.
    Krishnaswamy V; Kumarasamy T; Venkatesan V; Shroff S; Jayanth VR; Paul SFD
    J Hum Genet; 2006; 51(3):254-257. PubMed ID: 16437189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor CAG repeat polymorphism and risk of TMPRSS2:ERG-positive prostate cancer.
    Yoo S; Pettersson A; Jordahl KM; Lis RT; Lindstrom S; Meisner A; Nuttall EJ; Stack EC; Stampfer MJ; Kraft P; Brown M; Loda M; Giovannucci EL; Kantoff PW; Mucci LA
    Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):2027-31. PubMed ID: 24925673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.